Encompass Health (EHC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Core Insights - Encompass Health (EHC) reported $1.46 billion in revenue for Q2 2025, a 12% year-over-year increase, with an EPS of $1.40 compared to $1.11 a year ago, exceeding Zacks Consensus Estimates for both revenue and EPS [1] - The company achieved a revenue surprise of +2.29% and an EPS surprise of +16.67% compared to analyst expectations [1] Financial Performance Metrics - Net patient revenue per discharge was $21,670, surpassing the two-analyst average estimate of $21,429.50 [4] - Total discharges were 65,237, slightly above the average estimate of 64,850 [4] - Net Operating Revenues for Inpatient services reached $1.41 billion, exceeding the average estimate of $1.39 billion, reflecting an 11.7% year-over-year increase [4] - Net Operating Revenues for Outpatient and other services were $44 million, above the average estimate of $43.19 million, showing a year-over-year increase of 23.3% [4] Stock Performance - Encompass Health shares have returned -8.8% over the past month, contrasting with the Zacks S&P 500 composite's +0.6% change [3] - The stock currently holds a Zacks Rank 2 (Buy), suggesting potential outperformance against the broader market in the near term [3]